The Portable Screening Tympanometer segmentation by application distinguishes four principal usage contexts: primary‑care facilities, otolaryngology (ENT) clinics, school‑based hearing‑screening programs, and home‑care settings. In primary‑care, the device functions as a first‑line diagnostic adjunct, enabling clinicians to triage middle‑ear pathologies without referral; this segment accounts for roughly 35 % of total revenue, driven by high patient volumes and reimbursement structures that favour point‑of‑care testing. ENT clinics, representing about 30 % of the market, demand higher precision and integration with electronic medical records, supporting specialist‑level diagnostics and longitudinal monitoring. School screening programs, contributing 20 % of sales, prioritize portability, rapid throughput, and low per‑unit cost to facilitate mass examinations of children; public‑health funding and mandated screening regulations underpin this demand. Home‑care usage, the smallest yet fastest‑growing slice at 15 %, is propelled by aging populations and tele‑audiology models that require battery‑operated, user‑friendly devices. Collectively, these application categories shape the overall market size and growth trajectory.